We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
UK Health Security Agency (UKHSA) risk assessment of avian influenza A(H7N4) following reports of the first human case in a person from China.
The risk to UK residents travelling to China is very low. This update includes information and advice for travellers and clinicians.
The risk to UK residents travelling to the affected areas is very low.
Latest developments in vaccines, vaccination policies and procedures for immunisation practitioners.
Resources for addressing health inequalities in antimicrobial resistance based on marriage and civil partnership status.
Privacy notice for private sector providers of coronavirus (COVID-19) testing who want to self-declare they meet minimum standards.
Advice for people who have been in possible contact with Lujo virus.
An explanation of how UKHSA processes your personal data when you apply to access it for secondary purposes
This guidance provides advice for everyone on how to stay safe during hot weather, including how to keep your home cool.
Examples of practice and shared learning from across settings to support understanding and action on AMR-related health inequalities.
Advice for those who were in The Mill pub or Zizzi restaurant in Salisbury on Sunday 4 or Monday 5 March 2018.
This leaflet explains the measles mumps rubella (MMR) vaccine to young people who may have missed their routine MMR vaccinations.
Monitoring and evaluation of doxycycline post-exposure prophylaxis (doxyPEP) in England to protect people at high risk of syphilis.
Evidence and guidance to enable health and care professionals to promote the benefits of immunisation.
Guidance to assist staff involved with the collection, recording, analysis and interpretation of data from CTAD and GUMCAD.
Information for healthcare professionals on the clinical investigation and management of COVID-19 vaccine induced thrombosis and thrombocytopenia (VITT).
Do not include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).